Literature DB >> 2121135

Purification, properties and partial amino acid sequence of the blood-group-A-gene-associated alpha-3-N-acetylgalactosaminyltransferase from human gut mucosal tissue.

N Navaratnam1, J B Findlay, J N Keen, W M Watkins.   

Abstract

An alpha-3-N-acetylgalactosaminyltransferase that transfers N-acetylgalactosamine from UDP-N-acetylgalactosamine to H-active structures to form A determinants was purified to homogeneity from human gut mucosal tissue of blood-group-A subjects. The mucosa was homogenized, then treated with Triton X-100, and the solubilized enzyme was purified by affinity chromatography on UDP-hexanolamine-agarose and octyl-Sepharose CL-4B. Enzyme activity was recovered in 44% yield with a specific activity of approx. 7 mumol/min per mg. The only effective acceptor substrates for the transferase were those containing a subterminal beta-galactosyl residue substituted at the O-2 position with L-fucose. The purified enzyme had a weak capacity to transfer D-galactose from UDP-D-galactose to similar acceptors to make blood-group-B determinants. H.p.l.c. and SDS/PAGE analysis indicated an Mr of 40,000 for the purified enzyme. For the first time a partial amino acid sequence Xaa-Ser-Leu-Pro-Arg-Met-Val-Tyr-Pro-Gln-Ile-Ser?-Val-Leu was obtained for the N-terminal region of the soluble alpha-3-N-acetylgalactosaminyltransferase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121135      PMCID: PMC1149517          DOI: 10.1042/bj2710093

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  Possible genetical pathways for the biosynthesis of blood group mucopolysaccharides.

Authors:  W M WATKINS; W T MORGAN
Journal:  Vox Sang       Date:  1959-04       Impact factor: 2.144

2.  Qualitative differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and A2 genes.

Authors:  H Schachter; M A Michaels; C A Tilley; M C Crookston; J H Crookston
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

3.  An N-acetylgalactosaminyltransferase from human blood group A plasma. II. Kinetic and physicochemical properties.

Authors:  J S Whitehead; S Bella; Y S Kim
Journal:  J Biol Chem       Date:  1974-06-10       Impact factor: 5.157

4.  Occurrence and assay of alpha-N-acetylgalactosaminyl transferase in the gastric mucosa of humans belonging to blood group A.

Authors:  H Tuppy; H Schenkel-Brunner
Journal:  Vox Sang       Date:  1969-08       Impact factor: 2.144

5.  An enzymic basis for blood type A in humans.

Authors:  A Kobata; E F Grollman; V Ginsburg
Journal:  Arch Biochem Biophys       Date:  1968-03-20       Impact factor: 4.013

6.  Solid-phase Edman degradation. An automatic peptide sequencer.

Authors:  R A Laursen
Journal:  Eur J Biochem       Date:  1971-05-11

7.  Isolectric points of the human blood group A-1, A-2 and B gene-associated glycosyltransferases in ovarian cyst fluids and serum.

Authors:  M D Topping; W M Watkins
Journal:  Biochem Biophys Res Commun       Date:  1975-05-05       Impact factor: 3.575

Review 8.  [Quantitative and thermodynamic study of weak A erythrocyte phenotypes].

Authors:  J P Cartron
Journal:  Rev Fr Transfus Immunohematol       Date:  1976-03

9.  Study of the alpha-N-acetylgalactosaminyltransferase in sera and red cell membranes of human A subgroups.

Authors:  J P Cartron; J Badet; C Mulet; C Salmon
Journal:  J Immunogenet       Date:  1978-04

10.  Human blood group glycosyltransferases. I. Purification of n-acetylgalactosaminyltransferase.

Authors:  M Nagai; V Davè; B E Kaplan; A Yoshida
Journal:  J Biol Chem       Date:  1978-01-25       Impact factor: 5.157

View more
  2 in total

1.  Unravelling the biochemical basis of blood group ABO and Lewis antigenic specificity.

Authors:  W T Morgan; W M Watkins
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

2.  Enzyme-linked immunosorbent assays for the measurement of blood group A and B glycosyltransferase activities.

Authors:  L M Keshvara; E M Newton; A H Good; O Hindsgaul; M M Palcic
Journal:  Glycoconj J       Date:  1992-02       Impact factor: 2.916

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.